Clinical Trial Update: Once Weekly D-cycloserine for Schizophrenia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating once-weekly D-cycloserine for schizophrenia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• D-cycloserine (D-cycloserine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Schizophrenia | Phase 4 | Status: WITHDRAWN